Immunotherapy treatment could be improved by blocking molecules that help tumour blood vessels grow, according to two new lab-based studies.
A number of cancer clinical trials involving immunotherapy treatments appear to be showing promise, according to new research.
This year’s British Science Week runs from 10th – 19th March, and the theme is ‘change’.
Cancer treatments that harness the power of the immune system might be less effective in patients whose tumours carry incorrectly packaged DNA.
A drug that ‘reinvigorates the immune system’ can extend the lives of lung cancer patients with reduced side effects.
Read our final roundup from this year's NCRI Cancer Conference, including how bacteria in the gut could help predict if immunotherapy will work.
A weight loss condition frequently seen in cancer patients could provide answers as to why certain immunotherapy treatments fail in some patients.
Patients with malignant melanoma are more likely to respond to immunotherapy treatment if they had greater diversity in their gut bacteria.
Specialised immune cells can become ‘exhausted’ following immunotherapy to treat cancer, limiting the treatment’s effectiveness in some people.